Drug Pipeline

Tyrosine Kinase Inhibitor Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-21 NCT03817398
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients…		 date change Primary completion pushed: 2026-06-30 -> 2026-09-30
2026-05-21 NCT03817398
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients…		 date change Completion pushed: 2026-06-30 -> 2026-09-30
Active Studies by Phase
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04318938 Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping NSCLC Active, Not Recruiting
NCT03817398 Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients… Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Active, Not Recruiting
Not specified
NCT03958565 Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers… Carcinoma, Non-Small-Cell Lung Recruiting
Sponsors Running Tyrosine Kinase Inhibitor Trials
Children's Oncology Group (1) University of Colorado, Denver (1) Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Leukemia (1) Chronic Myeloid Leukemia (CML) (1)
Get alerts when Tyrosine Kinase Inhibitor trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free